{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:11:10Z","timestamp":1779448270793,"version":"3.53.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11986-6","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:42:43Z","timestamp":1779442963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deubiquitinases at the crossroads of ferroptosis and cancer therapy: mechanisms and therapeutic potential"],"prefix":"10.1007","volume":"53","author":[{"given":"Amr Ali Mohamed Abdelgawwad","family":"El-Sehrawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaya Nadhim","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitham L.","family":"Abdulhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj A.","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina Saeed","family":"Basunduwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimal","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya Priyadarshini","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wessam T.","family":"Muslem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"1","key":"11986_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, Sun Y, Zeng F, Chen X, Deng G (2024) Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther 9(1):55","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"11986_CR2","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.7150\/ijbs.66917","volume":"18","author":"YB Zuo","year":"2022","unstructured":"Zuo YB, Zhang YF, Zhang R, Tian JW, Lv XB, Li R, Li SP, Cheng MD, Shan J, Zhao Z et al (2022) Ferroptosis in Cancer Progression: Role of Noncoding RNAs. Int J Biol Sci 18(5):1829\u20131843","journal-title":"Int J Biol Sci"},{"key":"11986_CR3","doi-asserted-by":"crossref","unstructured":"Zhang R, Chen J, Wang S, Zhang W, Zheng Q, Cai R (2023) Ferroptosis in Cancer Progression. Cells 12(14)","DOI":"10.3390\/cells12141820"},{"key":"11986_CR4","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.drup.2022.100916","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, Wang H (2023) Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat 66:100916","journal-title":"Drug Resist Updat"},{"issue":"1","key":"11986_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, Li B (2019) Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol 12(1):34","journal-title":"J Hematol Oncol"},{"issue":"9","key":"11986_CR6","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41556-024-01425-8","volume":"26","author":"T Nakamura","year":"2024","unstructured":"Nakamura T, Conrad M (2024) Exploiting ferroptosis vulnerabilities in cancer. Nat Cell Biol 26(9):1407\u20131419","journal-title":"Nat Cell Biol"},{"issue":"8","key":"11986_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lu S, Wu LL, Yang L, Yang L, Wang J (2023) The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis 14(8):519","journal-title":"Cell Death Dis"},{"issue":"4","key":"11986_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"11986_CR9","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1186\/s12967-024-05565-1","volume":"22","author":"Y Wu","year":"2024","unstructured":"Wu Y, Chen Y, Tian X, Shao G, Lin Q, Sun A (2024) Ubiquitination regulates autophagy in cancer: simple modifications, promising targets. J Transl Med 22(1):985","journal-title":"J Transl Med"},{"issue":"1","key":"11986_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13046-023-02920-w","volume":"43","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Huang Z, Li K, Xie G, Feng Y, Wang Z, Li N, Liu R, Ding Y, Wang J et al (2024) TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression. J Exp Clin Cancer Res 43(1):16","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"11986_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, Lu B, Fan Y, Liu Z, Chen X et al (2024) Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer 23(1):148","journal-title":"Mol Cancer"},{"key":"11986_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.biocel.2018.06.001","volume":"101","author":"MA Mansour","year":"2018","unstructured":"Mansour MA (2018) Ubiquitination: Friend and foe in cancer. Int J Biochem Cell Biol 101:80\u201393","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"11986_CR13","doi-asserted-by":"publisher","first-page":"194979","DOI":"10.1016\/j.bbagrm.2023.194979","volume":"1866","author":"G Dagar","year":"2023","unstructured":"Dagar G, Kumar R, Yadav KK, Singh M, Pandita TK (2023) Ubiquitination and deubiquitination: Implications on cancer therapy. Biochim Biophys Acta Gene Regul Mech 1866(4):194979","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"12","key":"11986_CR14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","volume":"23","author":"G Dewson","year":"2023","unstructured":"Dewson G, Eichhorn PJA, Komander D (2023) Deubiquitinases in cancer. Nat Rev Cancer 23(12):842\u2013862","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"11986_CR15","doi-asserted-by":"publisher","first-page":"12636","DOI":"10.1080\/21655979.2021.2011633","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao X, Zhou M, Yang Y, Luo M (2021) The ubiquitin hydrolase OTUB1 promotes glioma cell stemness via suppressing ferroptosis through stabilizing SLC7A11 protein. Bioengineered 12(2):12636\u201312645","journal-title":"Bioengineered"},{"issue":"3","key":"11986_CR16","doi-asserted-by":"publisher","first-page":"e70257","DOI":"10.1002\/ctm2.70257","volume":"15","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Zhao Z, Jiang C, Nie C, Xiao D, Wu Z, Yu H, Zheng J, Wang X, Jiang X (2025) LINC01088 prevents ferroptosis in glioblastoma by enhancing SLC7A11 via HLTF\/USP7 axis. Clin Translational Med 15(3):e70257","journal-title":"Clin Translational Med"},{"issue":"5","key":"11986_CR17","doi-asserted-by":"publisher","first-page":"115681","DOI":"10.1016\/j.celrep.2025.115681","volume":"44","author":"J Chen","year":"2025","unstructured":"Chen J, Huang C, Mei J, Lin Q, Chen W, Tang J, Wei X, Mo C, Zhang Y, Zeng Q et al (2025) OTUD4 inhibits ferroptosis by stabilizing GPX4 and suppressing autophagic degradation to promote tumor progression. Cell Rep 44(5):115681","journal-title":"Cell Rep"},{"issue":"5","key":"11986_CR18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41416-024-02574-1","volume":"130","author":"Y Chen","year":"2024","unstructured":"Chen Y, Feng Y, Lin Y, Zhou X, Wang L, Zhou Y, Lin K, Cai L (2024) GSTM3 enhances radiosensitivity of nasopharyngeal carcinoma by promoting radiation-induced ferroptosis through USP14\/FASN axis and GPX4. Br J Cancer 130(5):755\u2013768","journal-title":"Br J Cancer"},{"key":"11986_CR19","doi-asserted-by":"publisher","first-page":"151990","DOI":"10.1016\/j.bbrc.2025.151990","volume":"770","author":"Q Ding","year":"2025","unstructured":"Ding Q, Zhuang Y, Yang H-y (2025) Zhao X-n, Sun Y-n: USP31 confers radio-resistance in cervical cancer cells via ferroptosis pathway by deubiquitinating and stabilizing GPX4. Biochem Biophys Res Commun 770:151990\u2013151990","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"11986_CR20","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T (2019) Targeting Ferroptosis to Iron Out Cancer. Cancer Cell 35(6):830\u2013849","journal-title":"Cancer Cell"},{"issue":"3","key":"11986_CR21","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/tox.23992","volume":"39","author":"F Lian","year":"2024","unstructured":"Lian F, Dong D, Pu J, Yang G, Yang J, Yang S, Wang Y, Zhao B, Lu M (2024) Ubiquitin-specific peptidase 10 attenuates the ferroptosis to promote thyroid cancer malignancy by facilitating GPX4 via elevating SIRT6. Environ Toxicol 39(3):1129\u20131139","journal-title":"Environ Toxicol"},{"key":"11986_CR22","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/s12672-025-03022-z","volume":"16","author":"G Lin","year":"2025","unstructured":"Lin G, Lin X, Lin Q, Zhao J (2025) OTUB1 promotes colorectal cancer progression by stabilizing GPX4 and inhibiting ferroptosis. Discover Oncol 16:1240","journal-title":"Discover Oncol"},{"issue":"6","key":"11986_CR23","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s10120-025-01645-3","volume":"28","author":"X Zhao","year":"2025","unstructured":"Zhao X, Lu S, Yan M, Zhu ZG, Dong F, Yan C (2025) Resveratrol targets mitochondrial USP36-SOD2 to induce autophagy-ferroptosis and inhibit gastric cancer progression. Gastric Cancer 28(6):1067\u20131084","journal-title":"Gastric Cancer"},{"issue":"18","key":"11986_CR24","doi-asserted-by":"publisher","first-page":"e2307899","DOI":"10.1002\/advs.202307899","volume":"11","author":"X Guan","year":"2024","unstructured":"Guan X, Wang Y, Yu W, Wei Y, Lu Y, Dai E, Dong X, Zhao B, Hu C, Yuan L et al (2024) Blocking Ubiquitin-Specific Protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl-CoA Desaturase. Adv Sci (Weinh) 11(18):e2307899","journal-title":"Adv Sci (Weinh)"},{"key":"11986_CR25","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3389\/fonc.2020.00949","volume":"10","author":"L Yang","year":"2020","unstructured":"Yang L, Chen X, Yang Q, Chen J, Huang Q, Yao L, Yan D, Wu J, Zhang P, Tang D (2020) Broad spectrum deubiquitinase inhibition induces both apoptosis and ferroptosis in cancer cells. Front Oncol 10:949","journal-title":"Front Oncol"},{"issue":"5","key":"11986_CR26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.neo.2021.03.009","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen S, Bu D, Zhu J, Yue T, Guo S, Wang X, Pan Y, Liu Y, Wang P (2021) Endogenous hydrogen sulfide regulates xCT stability through persulfidation of OTUB1 at cysteine 91 in colon cancer cells. Neoplasia (New York NY) 23(5):461","journal-title":"Neoplasia (New York NY)"},{"issue":"1","key":"11986_CR27","doi-asserted-by":"publisher","first-page":"12351","DOI":"10.1038\/s41598-025-96868-w","volume":"15","author":"Z Wu","year":"2025","unstructured":"Wu Z, Zhang F, Yang K, He W (2025) CircSCD1 inhibits ferroptosis in breast Cancer through stabilizing SCD1 protein via deubiquitinase OTUB1. Sci Rep 15(1):12351","journal-title":"Sci Rep"},{"issue":"3","key":"11986_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/15548627.2024.2410619","volume":"21","author":"L Chen","year":"2025","unstructured":"Chen L, Ning J, Linghu L, Tang J, Liu N, Long Y, Sun J, Lv C, Shi Y, Tao T (2025) USP13 facilitates a ferroptosis-to-autophagy switch by activation of the NFE2L2\/NRF2-SQSTM1\/p62-KEAP1 axis dependent on the KRAS signaling pathway. Autophagy 21(3):565\u2013582","journal-title":"Autophagy"},{"key":"11986_CR29","doi-asserted-by":"crossref","unstructured":"Xie J, Ma C, Zhao S, Wu D, Zhang P, Tang Q, Ni T, Yan W, Qi M (2025) Deubiquitination by USP7 stabilizes JunD and activates AIFM2 (FSP1) to inhibit ferroptosis in melanoma. J Invest Dermatology","DOI":"10.1016\/j.jid.2025.03.018"},{"issue":"1","key":"11986_CR30","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41419-025-07895-4","volume":"16","author":"L Yang","year":"2025","unstructured":"Yang L, An X, Yang S, Lin X, Chen Z, Xue Q, Chen X, Wang Y, Yan D, Chen S et al (2025) The deubiquitinase USP24 suppresses ferroptosis in triple-negative breast cancer by stabilizing DHODH protein. Cell Death Dis 16(1):564","journal-title":"Cell Death Dis"},{"key":"11986_CR31","doi-asserted-by":"publisher","first-page":"217232","DOI":"10.1016\/j.canlet.2024.217232","volume":"604","author":"X Liu","year":"2024","unstructured":"Liu X, Ma Z, Jing X, Wang G, Zhao L, Zhao X, Zhang Y (2024) The deubiquitinase OTUD5 stabilizes SLC7A11 to promote progression and reduce paclitaxel sensitivity in triple-negative breast cancer. Cancer Lett 604:217232","journal-title":"Cancer Lett"},{"issue":"1","key":"11986_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s42003-025-07513-1","volume":"8","author":"J Cao","year":"2025","unstructured":"Cao J, Wu T, Zhou T, Jiang Z, Ren Y, Yu J, Wang J, Qian C, Wu G, He L (2025) USP35 promotes the growth of ER positive breast cancer by inhibiting ferroptosis via BRD4-SLC7A11 axis. Commun Biology 8(1):64","journal-title":"Commun Biology"},{"key":"11986_CR33","doi-asserted-by":"crossref","unstructured":"Shen N, Xia Y, Shen X, Hua W, Shi M, Chen L (2025) HSPA9 contributes to tumor progression and ferroptosis resistance by enhancing USP14-driven SLC7A11 deubiquitination in multiple myeloma. Cell Rep 44(5)","DOI":"10.1016\/j.celrep.2025.115720"},{"issue":"36","key":"11986_CR34","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1038\/s41388-023-02744-0","volume":"42","author":"Z Wang","year":"2023","unstructured":"Wang Z, Ouyang L, Liu N, Li T, Yan B, Mao C, Xiao D, Gan B, Liu S, Tao Y (2023) The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis. Oncogene 42(36):2688\u20132700","journal-title":"Oncogene"},{"issue":"3","key":"11986_CR35","doi-asserted-by":"publisher","first-page":"e70271","DOI":"10.1002\/ctm2.70271","volume":"15","author":"J Zhang","year":"2025","unstructured":"Zhang J, Tian T, Li X, Xu K, Lu Y, Li X, Zhao X, Cui Z, Wang Z, Zhou Y (2025) p53 inhibits OTUD5 transcription to promote GPX4 degradation and induce ferroptosis in gastric cancer. Clin Translational Med 15(3):e70271","journal-title":"Clin Translational Med"},{"issue":"1","key":"11986_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41419-025-07807-6","volume":"16","author":"X Yue","year":"2025","unstructured":"Yue X, Xiang Z, Yi Y, Wang X, Zhou W, Wu W, Qin W, Zhao Y, Bu X, Peng Z (2025) Targeting the TRIM14\/USP14 axis enhances radiotherapy efficacy by inducing GPX4 degradation and disrupting ferroptotic defense in HCC. Cell Death Dis 16(1):481","journal-title":"Cell Death Dis"},{"issue":"1","key":"11986_CR37","doi-asserted-by":"publisher","first-page":"bgae060","DOI":"10.1093\/carcin\/bgae060","volume":"46","author":"Y Ding","year":"2025","unstructured":"Ding Y, Liu Z, Dai X, Ruan R, Zhong H, Wu Z, Yao Y, Chen J, Deng J, Xiong J (2025) Ubiquitin-specific peptidase 49 promotes adenocarcinoma of the esophagogastric junction malignant progression via activating SHCBP1\u2013\u03b2-catenin\u2013GPX4 axis. Carcinogenesis 46(1):bgae060","journal-title":"Carcinogenesis"},{"key":"11986_CR38","doi-asserted-by":"crossref","unstructured":"Zhang D, Wang X, Lu S, Gao Y, Zhu G, Li G, Yu Z, Hou J, Yan H, Yuan W (2025) USP10 Inhibits Ferroptosis via Deubiquinating POLR2A in Head and Neck Squamous Cell Carcinoma. Adv Sci :e12271","DOI":"10.1002\/advs.202412271"},{"issue":"14","key":"11986_CR39","doi-asserted-by":"publisher","first-page":"e70880","DOI":"10.1096\/fj.202501018R","volume":"39","author":"X Xie","year":"2025","unstructured":"Xie X, Zhang Y, Li Y, Guo N, Guo X, Wang F, Ren K, Yu J, Wu F (2025) Deubiquitinase OTUD4 Stabilizes SLC5A2 to Promote Pancreatic Cancer Proliferation and Migration Through Enchaining Glycolysis-Mediated Autophagy. Faseb j 39(14):e70880","journal-title":"Faseb j"},{"issue":"1","key":"11986_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/antiox13010114","volume":"13","author":"H Tao","year":"2024","unstructured":"Tao H, Song S-J, Fan Z-W, Li W-T, Jin X, Jiang W, Bai J, Shi Z-Z (2024) PKCiota inhibits the ferroptosis of esophageal cancer cells via suppressing USP14-mediated autophagic degradation of GPX4. Antioxidants 13(1):114","journal-title":"Antioxidants"},{"issue":"6","key":"11986_CR41","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41419-023-05747-7","volume":"14","author":"J Tang","year":"2023","unstructured":"Tang J, Long G, Xiao L, Zhou L (2023) USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through \u03b2-catenin stabilization. Cell Death Dis 14(6):360","journal-title":"Cell Death Dis"},{"key":"11986_CR42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.freeradbiomed.2023.11.030","volume":"212","author":"G Long","year":"2024","unstructured":"Long G, Wu Z, Wang D, Mi X, Hu K, Zhou L, Tang J (2024) UCHL3 inhibits ferroptosis by stabilizing \u03b2-catenin and maintains stem-like properties of hepatocellular carcinoma cells. Free Radic Biol Med 212:162\u2013173","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"11986_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41419-024-06464-5","volume":"15","author":"Y Gu","year":"2024","unstructured":"Gu Y, Wu S, Fan J, Meng Z, Gao G, Liu T, Wang Q, Xia H, Wang X, Wu K (2024) CYLD regulates cell ferroptosis through Hippo\/YAP signaling in prostate cancer progression. Cell Death Dis 15(1):79","journal-title":"Cell Death Dis"},{"issue":"5","key":"11986_CR44","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/jog.15922","volume":"50","author":"F Liu","year":"2024","unstructured":"Liu F, Zhang Y, Xia X, Han J, Cao L (2024) Honokiol induces ferroptosis in ovarian cancer cells through the regulation of YAP by OTUB2. J Obstet Gynecol Res 50(5):864\u2013872","journal-title":"J Obstet Gynecol Res"},{"key":"11986_CR45","doi-asserted-by":"crossref","unstructured":"Zhao S, Liu X, Luo R, Jian Z, Xu C, Hou Y, Liu X, Zhang P (2025) USP38 functions as an oncoprotein by downregulating the p53 pathway through deubiquitination and stabilization of MDM2. Cell Death Differ :1\u201314","DOI":"10.1038\/s41418-025-01462-2"},{"issue":"1","key":"11986_CR46","first-page":"166884","volume":"1870","author":"W Yang","year":"2024","unstructured":"Yang W, Wang S, Tong S, Zhang W-D, Qin J-J (2024) Expanding the ubiquitin code in pancreatic cancer. Biochim et Biophys Acta (BBA)-Molecular Basis Disease 1870(1):166884","journal-title":"Biochim et Biophys Acta (BBA)-Molecular Basis Disease"},{"issue":"1","key":"11986_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s42003-022-03133-1","volume":"5","author":"X Fu","year":"2022","unstructured":"Fu X, Zhao J, Yu G, Zhang X, Sun J, Li L, Yin J, Niu Y, Ren S, Zhu Y (2022) OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR. Commun Biology 5(1):182","journal-title":"Commun Biology"},{"key":"11986_CR48","doi-asserted-by":"crossref","unstructured":"Ye Y, Wang P, Wu D, Tang F, Shen N, Hou G (2025) Deubiquitinating enzyme UCHL1 stabilizes CAV1 to inhibit ferroptosis and enhance docetaxel resistance in nasopharyngeal carcinoma. Anticancer Drugs :101097","DOI":"10.1097\/CAD.0000000000001721"},{"issue":"4","key":"11986_CR49","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.1002\/ctm2.390","volume":"11","author":"Z Tang","year":"2021","unstructured":"Tang Z, Jiang W, Mao M, Zhao J, Chen J, Cheng N (2021) Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin. Clin translational Med 11(4):e390","journal-title":"Clin translational Med"},{"issue":"26","key":"11986_CR50","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1038\/s41388-024-03050-z","volume":"43","author":"J Song","year":"2024","unstructured":"Song J, Zhang J, Shi Y, Gao Q, Chen H, Ding X, Zhao M, Zhu C, Liang L, Sun X (2024) Hypoxia inhibits ferritinophagy-mediated ferroptosis in esophageal squamous cell carcinoma via the USP2-NCOA4 axis. Oncogene 43(26):2000\u20132014","journal-title":"Oncogene"},{"issue":"2","key":"11986_CR51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/pin.13190","volume":"72","author":"T Ogura","year":"2022","unstructured":"Ogura T, Azuma K, Takeiwa T, Sato J, Kinowaki K, Ikeda K, Kawabata H, Inoue S (2022) TRIM39 is a poor prognostic factor for patients with estrogen receptor-positive breast cancer and promotes cell cycle progression. Pathol Int 72(2):96\u2013106","journal-title":"Pathol Int"},{"issue":"9","key":"11986_CR52","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1111\/jcmm.13694","volume":"22","author":"Z Liu","year":"2018","unstructured":"Liu Z, Zhang J, Xu J, Yang H, Li X, Hou Y, Zhao Y, Xue M, Wang B, Yu N (2018) RNF 168 facilitates oestrogen receptor \u0251 transcription and drives breast cancer proliferation. J Cell Mol Med 22(9):4161\u20134170","journal-title":"J Cell Mol Med"},{"issue":"1","key":"11986_CR53","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41523-025-00779-y","volume":"11","author":"X Yao","year":"2025","unstructured":"Yao X, Shen X, Fan Y, Wang H (2025) TRIM39-mediated deubiquitination upregulates RNF168 to evade autophagy-ferroptosis in triple-negative breast cancer. npj Breast Cancer 11(1):108","journal-title":"npj Breast Cancer"},{"issue":"1","key":"11986_CR54","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s42003-024-06999-5","volume":"7","author":"J Cao","year":"2024","unstructured":"Cao J, Wu S, Zhao S, Wang L, Wu Y, Song L, Sun C, Liu Y, Liu Z, Zhu R (2024) USP24 promotes autophagy-dependent ferroptosis in hepatocellular carcinoma by reducing the K48-linked ubiquitination of Beclin1. Commun Biology 7(1):1279","journal-title":"Commun Biology"},{"issue":"8","key":"11986_CR55","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1002\/ijc.29707","volume":"138","author":"ME Armijo","year":"2016","unstructured":"Armijo ME, Campos T, Fuentes-Villalobos F, Palma ME, Pincheira R, Castro AF (2016) Rheb signaling and tumorigenesis: mTORC1 and new horizons. Int J Cancer 138(8):1815\u20131823","journal-title":"Int J Cancer"},{"issue":"8","key":"11986_CR56","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.2174\/138945011795906589","volume":"12","author":"T Babcock","year":"2011","unstructured":"Babcock T, Quilliam JA (2011) Rheb\/mTOR activation and regulation in cancer: novel treatment strategies beyond rapamycin. Curr Drug Targets 12(8):1223\u20131231","journal-title":"Curr Drug Targets"},{"key":"11986_CR57","doi-asserted-by":"publisher","first-page":"110193","DOI":"10.1016\/j.abb.2024.110193","volume":"762","author":"D Yang","year":"2024","unstructured":"Yang D, Liu X, Yang Y, Long Y, Nan D, Shi B, Wang J, Yang M, Cong H, Xing L (2024) Pharmacological USP2 targeting suppresses ovarian cancer growth by potentiating apoptosis and ferroptosis. Arch Biochem Biophys 762:110193","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"11986_CR58","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1002\/mco2.337","volume":"4","author":"B Yan","year":"2023","unstructured":"Yan B, Guo J, Wang Z, Ning J, Wang H, Shu L, Hu K, Chen L, Shi Y, Zhang L (2023) The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression. MedComm 4(4):e337","journal-title":"MedComm"},{"issue":"6","key":"11986_CR59","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/CAD.0000000000001562","volume":"35","author":"R Tao","year":"2024","unstructured":"Tao R, Liu Z, Zhang Z, Zhang Z (2024) USP3 promotes cisplatin resistance in non-small cell lung cancer cells by suppressing ACOT7-regulated ferroptosis. Anticancer Drugs 35(6):483\u2013491","journal-title":"Anticancer Drugs"},{"issue":"10","key":"11986_CR60","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, Sirohi K, Li X, Wei Y, Lee H (2018) BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol 20(10):1181\u20131192","journal-title":"Nat Cell Biol"},{"key":"11986_CR61","doi-asserted-by":"publisher","first-page":"117309","DOI":"10.1016\/j.biopha.2024.117309","volume":"179","author":"H Peng","year":"2024","unstructured":"Peng H, He Y, Hu Y, Sheng S, Maitiyasen M, Liu Y, Hou X, Song H, Yi J (2024) Berbamine promotes ferroptosis of esophageal squamous cell carcinoma by facilitating USP51-mediated GPX4 ubiquitination and degradation. Biomed Pharmacother 179:117309","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"11986_CR62","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s40618-024-02385-4","volume":"47","author":"J Ma","year":"2024","unstructured":"Ma J, Li Z, Xu J, Lai J, Zhao J, Ma L, Sun X (2024) PRDM1 promotes the ferroptosis and immune escape of thyroid cancer by regulating USP15-mediated SELENBP1 deubiquitination. J Endocrinol Investig 47(12):2981\u20132997","journal-title":"J Endocrinol Investig"},{"issue":"21","key":"11986_CR63","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.3390\/cancers14215233","volume":"14","author":"W Zhang","year":"2022","unstructured":"Zhang W, Li X, Xu J, Wang Y, Xing Z, Hu S, Fan Q, Lu S, Cheng J, Gu J (2022) The RSL3 induction of KLK lung adenocarcinoma cell ferroptosis by inhibition of USP11 activity and the NRF2-GSH axis. Cancers 14(21):5233","journal-title":"Cancers"},{"issue":"2","key":"11986_CR64","doi-asserted-by":"publisher","first-page":"e51162","DOI":"10.15252\/embr.202051162","volume":"22","author":"J Song","year":"2021","unstructured":"Song J, Liu T, Yin Y, Zhao W, Lin Z, Yin Y, Lu D, You F (2021) The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity. EMBO Rep 22(2):e51162","journal-title":"EMBO Rep"},{"issue":"3","key":"11986_CR65","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/imm.13683","volume":"170","author":"J Wu","year":"2023","unstructured":"Wu J, Liu C, Wang T, Liu H, Wei B (2023) Deubiquitinase inhibitor PR-619 potentiates colon cancer immunotherapy by inducing ferroptosis. Immunology 170(3):439\u2013451","journal-title":"Immunology"},{"key":"11986_CR66","doi-asserted-by":"publisher","first-page":"1027726","DOI":"10.3389\/fgene.2022.1027726","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, He Q (2022) The role of SELENBP1 and its epigenetic regulation in carcinogenic progression. Front Genet 13:1027726","journal-title":"Front Genet"},{"issue":"1","key":"11986_CR67","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12876-022-02532-2","volume":"22","author":"C Zhu","year":"2022","unstructured":"Zhu C, Wang S, Du Y, Dai Y, Huai Q, Li X, Du Y, Dai H, Yuan W, Yin S (2022) Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer. BMC Gastroenterol 22(1):437","journal-title":"BMC Gastroenterol"},{"issue":"35","key":"11986_CR68","doi-asserted-by":"publisher","first-page":"e4592","DOI":"10.1097\/MD.0000000000004592","volume":"95","author":"F Chen","year":"2016","unstructured":"Chen F, Chen C, Qu Y, Xiang H, Ai Q, Yang F, Tan X, Zhou Y, Jiang G, Zhang Z (2016) Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma. Medicine 95(35):e4592","journal-title":"Medicine"},{"issue":"10","key":"11986_CR69","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1038\/s41418-023-01219-9","volume":"30","author":"Z Kuang","year":"2023","unstructured":"Kuang Z, Liu X, Zhang N, Dong J, Sun C, Yin M, Wang Y, Liu L, Xiao D, Zhou X (2023) USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1. Cell Death Differ 30(10):2249\u20132264","journal-title":"Cell Death Differ"},{"key":"11986_CR70","doi-asserted-by":"publisher","first-page":"107668","DOI":"10.1016\/j.phrs.2025.107668","volume":"214","author":"F Shi","year":"2025","unstructured":"Shi F, Li G-J, Liu Y, Zhou H-M, Zhang Y, Wei S-Y, Zan B-J, Gao M, Chen F-S, Li B-X (2025) USP19 deficiency enhances T-cell-mediated antitumor immunity by promoting PD-L1 degradation in colorectal cancer. Pharmacol Res 214:107668","journal-title":"Pharmacol Res"},{"issue":"1","key":"11986_CR71","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1038\/s41467-022-33285-x","volume":"13","author":"D Shi","year":"2022","unstructured":"Shi D, Wu X, Jian Y, Wang J, Huang C, Mo S, Li Y, Li F, Zhang C, Zhang D (2022) USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer. Nat Commun 13(1):5644","journal-title":"Nat Commun"},{"issue":"9","key":"11986_CR72","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/biom14091191","volume":"14","author":"C Jifu","year":"2024","unstructured":"Jifu C, Lu L, Ding J, Lv M, Xia J, Wang J, Wang P (2024) USP18 is associated with PD-L1 antitumor immunity and improved prognosis in colorectal cancer. Biomolecules 14(9):1191","journal-title":"Biomolecules"},{"issue":"1","key":"11986_CR73","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s12885-025-13869-8","volume":"25","author":"X Pan","year":"2025","unstructured":"Pan X, Deng H (2025) Deubiquitinase USP18 mediates cell migration, apoptosis and ferroptosis in lung adenocarcinoma by depending on POU4F1\/PRKAA2 axis. BMC Cancer 25(1):528","journal-title":"BMC Cancer"},{"issue":"1","key":"11986_CR74","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41419-025-07772-0","volume":"16","author":"S Ye","year":"2025","unstructured":"Ye S, Chen J, Zheng Y, He M, Zhang Y, Cheng Y, Leng Y, Wu E, Kong L, Zhang H (2025) Targeting USP18 overcomes acquired resistance in hepatocellular carcinoma by regulating NCOA4 deISGylation and ferroptosis. Cell Death Dis 16(1):448","journal-title":"Cell Death Dis"},{"key":"11986_CR75","doi-asserted-by":"crossref","unstructured":"Zhou Y, Li H, Zhang Y, Zhao E, Huang C, Pan X, Shu F, Liu Z, Tang N, Li F (2024) Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer. Cancer Lett :216836","DOI":"10.1016\/j.canlet.2024.216836"},{"issue":"33","key":"11986_CR76","doi-asserted-by":"publisher","first-page":"2302953","DOI":"10.1002\/advs.202302953","volume":"10","author":"J Tang","year":"2023","unstructured":"Tang J, Long G, Hu K, Xiao D, Liu S, Xiao L, Zhou L, Tao Y (2023) Targeting USP8 inhibits O-GlcNAcylation of SLC7A11 to promote ferroptosis of hepatocellular carcinoma via stabilization of OGT. Adv Sci 10(33):2302953","journal-title":"Adv Sci"},{"issue":"1","key":"11986_CR77","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12920-025-02108-5","volume":"18","author":"Y Gong","year":"2025","unstructured":"Gong Y, Li R, Zhang R, Jia L (2025) USP2 reversed cisplatin resistance through p53-mediated ferroptosis in NSCLC. BMC Med Genom 18(1):39","journal-title":"BMC Med Genom"},{"issue":"31","key":"11986_CR78","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1111\/1759-7714.15439","volume":"15","author":"P Lu","year":"2024","unstructured":"Lu P, Li Z, Xu H (2024) USP22 promotes gefitinib resistance and inhibits ferroptosis in non-small cell lung cancer by deubiquitination of MDM2. Thorac cancer 15(31):2260\u20132271","journal-title":"Thorac cancer"},{"key":"11986_CR79","doi-asserted-by":"crossref","unstructured":"Qian J, Zhao Z, Ma L, Liu W, Song Y USP14 targets FABP5-mediated ferroptosis to promote proliferation and cisplatin resistance of HNSCC. Clin Transl Oncol 2025:1\u201316","DOI":"10.1007\/s12094-025-03857-6"},{"issue":"11","key":"11986_CR80","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1038\/s41418-019-0303-z","volume":"26","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Zhang Z-Y, Du H, Li S-Z, Tu R, Jia Y-f, Zheng Z, Song X-M, Du R-L, Zhang X-D (2019) DUB3 deubiquitinates and stabilizes NRF2 in chemotherapy resistance of colorectal cancer. Cell Death Differ 26(11):2300\u20132313","journal-title":"Cell Death Differ"},{"issue":"1","key":"11986_CR81","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D, Zhang Q, Lin D, Ge S, Bai M (2020) CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer 19(1):43","journal-title":"Mol Cancer"},{"issue":"1","key":"11986_CR82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41389-023-00458-2","volume":"12","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Jiang X, Yin K, Miao T, Lu H, Wang W, Ma L, Zhao Y, Liu C, Qiao Y (2023) USP35 promotes cell proliferation and chemotherapeutic resistance through stabilizing FUCA1 in colorectal cancer. Oncogenesis 12(1):12","journal-title":"Oncogenesis"},{"issue":"11","key":"11986_CR83","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.1007\/s00210-024-03174-9","volume":"397","author":"H Liu","year":"2024","unstructured":"Liu H, Gan Q, Lai Y, Pan Z, Jin Q, Li J, Wang N, Jiao S, Chai Y (2024) USP14 increases the sensitivity of retinoblastoma to cisplatin by mediating the ferroptosis. Naunyn Schmiedebergs Arch Pharmacol 397(11):8671\u20138680","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"17","key":"11986_CR84","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.scib.2021.01.027","volume":"66","author":"L Xiang","year":"2021","unstructured":"Xiang L, Zeng Q, Liu J, Xiao M, He D, Zhang Q, Xie D, Deng M, Zhu Y, Liu Y (2021) MAFG-AS1\/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis. Sci Bull 66(17):1773\u20131788","journal-title":"Sci Bull"},{"key":"11986_CR85","doi-asserted-by":"crossref","unstructured":"Wang S, Yang J, You L, Dai M, Zhao Y GSTM3 function and polymorphism in cancer: emerging but promising. Cancer Manage Res 2020:10377\u201310388","DOI":"10.2147\/CMAR.S272467"},{"issue":"1","key":"11986_CR86","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1186\/s12885-025-14946-8","volume":"25","author":"D Seven","year":"2025","unstructured":"Seven D, Dalan AB, Bayrak \u00d6F (2025) Targeting GSTM3 for therapeutic potential in advanced prostate cancer. BMC Cancer 25(1):1493","journal-title":"BMC Cancer"},{"issue":"4","key":"11986_CR87","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/pros.10348","volume":"58","author":"R Medeiros","year":"2004","unstructured":"Medeiros R, Vasconcelos A, Costa S, Pinto D, Ferreira P, Lobo F, Morais A, Oliveira J, Lopes C (2004) Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms. Prostate 58(4):414\u2013420","journal-title":"Prostate"},{"issue":"31","key":"11986_CR88","doi-asserted-by":"publisher","first-page":"21696","DOI":"10.18632\/oncotarget.24796","volume":"9","author":"A Checa-Rojas","year":"2018","unstructured":"Checa-Rojas A, Delgadillo-Silva LF, del Castillo Velasco-Herrera M, Andrade-Dom\u00ednguez A, Gil J, Santill\u00e1n O, Lozano L, Toledo-Leyva A, Ram\u00edrez-Torres A, Talamas-Rohana P (2018) GSTM3 and GSTP1: novel players driving tumor progression in cervical cancer. Oncotarget 9(31):21696","journal-title":"Oncotarget"},{"issue":"8","key":"11986_CR89","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1016\/j.apsb.2023.05.017","volume":"13","author":"X Yue","year":"2023","unstructured":"Yue X, Liu T, Wang X, Wu W, Wen G, Yi Y, Wu J, Wang Z, Zhan W, Wu R (2023) Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1\u2013BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy. Acta Pharm Sinica B 13(8):3382\u20133399","journal-title":"Acta Pharm Sinica B"},{"issue":"18","key":"11986_CR90","doi-asserted-by":"publisher","first-page":"2307899","DOI":"10.1002\/advs.202307899","volume":"11","author":"X Guan","year":"2024","unstructured":"Guan X, Wang Y, Yu W, Wei Y, Lu Y, Dai E, Dong X, Zhao B, Hu C, Yuan L (2024) Blocking ubiquitin-specific protease 7 induces ferroptosis in gastric cancer via targeting stearoyl\u2010CoA desaturase. Adv Sci 11(18):2307899","journal-title":"Adv Sci"},{"issue":"9","key":"11986_CR91","first-page":"2255","volume":"18","author":"SA Wang","year":"2024","unstructured":"Wang SA, Wu YC, Yang FM, Hsu FL, Zhang K, Hung JJ (2024) NCI677397 targeting USP24-mediated induction of lipid peroxidation induces ferroptosis in drug-resistant cancer cells. Mol Oncol 18(9):2255\u20132276","journal-title":"Mol Oncol"},{"key":"11986_CR92","doi-asserted-by":"publisher","first-page":"103788","DOI":"10.1016\/j.redox.2025.103788","volume":"85","author":"J Cao","year":"2025","unstructured":"Cao J, Chen X, Chen L, Lu Y, Wu Y, Deng A, Pan F, Huang H, Liu Y, Li Y et al (2025) DHODH-mediated mitochondrial redox homeostasis: a novel ferroptosis regulator and promising therapeutic target. Redox Biol 85:103788","journal-title":"Redox Biol"},{"key":"11986_CR93","doi-asserted-by":"crossref","unstructured":"Nowak \u0141, Krajewski W, Dejnaka E, Ma\u0142kiewicz B, Szyde\u0142ko T, Pawlak A (2023) Ubiquitin-Specific Proteases as Potential Therapeutic Targets in Bladder Cancer-In Vitro Evaluation of Degrasyn and PR-619 Activity Using Human and Canine Models. Biomedicines 11(3)","DOI":"10.3390\/biomedicines11030759"},{"key":"11986_CR94","doi-asserted-by":"crossref","unstructured":"Hsu FS, Lin WC, Kuo KL, Chiu YL, Hsu CH, Liao SM, Dong JR, Liu SH, Chang SC, Yang SP et al (2021) PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study. Int J Mol Sci 22(21)","DOI":"10.3390\/ijms222111706"},{"issue":"11","key":"11986_CR95","doi-asserted-by":"publisher","first-page":"114917","DOI":"10.1016\/j.celrep.2024.114917","volume":"43","author":"B Huang","year":"2024","unstructured":"Huang B, Cao D, Yuan X, Xiong Y, Chen B, Wang Y, Niu X, Tian R, Huang H (2024) USP7 deubiquitinates KRAS and promotes non-small cell lung cancer. Cell Rep 43(11):114917","journal-title":"Cell Rep"},{"key":"11986_CR96","doi-asserted-by":"publisher","first-page":"104907","DOI":"10.1016\/j.critrevonc.2025.104907","volume":"214","author":"M Ebrahimnezhad","year":"2025","unstructured":"Ebrahimnezhad M, Valizadeh A, Yousefi B (2025) Ferroptosis and immunotherapy: Breaking barriers in cancer treatment resistance. Crit Rev Oncol Hematol 214:104907","journal-title":"Crit Rev Oncol Hematol"},{"key":"11986_CR97","doi-asserted-by":"crossref","unstructured":"Tao B, Wang Z, Wang X, Song A, Liu J, Wang J, Zhang Q, Chen Z, Wang Z, Xu W et al (2025) An inherited predisposition allele promotes gastric cancer via enhancing deubiquitination-mediated activation of epithelial-to-mesenchymal transition signaling. J Clin Invest 135(8)","DOI":"10.1172\/JCI179617"},{"issue":"5\u20136","key":"11986_CR98","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s10495-025-02095-z","volume":"30","author":"C Liu","year":"2025","unstructured":"Liu C, Yuan Y, Zhan Y, Zou M, Wu L, Zhang C, Chen B, Zeng H, Yang R, Hu T et al (2025) Role of the USP family in autophagy regulation and cancer progression. Apoptosis 30(5\u20136):1133\u20131151","journal-title":"Apoptosis"},{"key":"11986_CR99","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2021.05.004","volume":"514","author":"T Feng","year":"2021","unstructured":"Feng T, Ling S, Xu C, Ying L, Su D, Xu X (2021) Ubiquitin-specific peptidase 22 in cancer. Cancer Lett 514:30\u201337","journal-title":"Cancer Lett"},{"key":"11986_CR100","doi-asserted-by":"crossref","unstructured":"Kitamura H (2023) Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders. Int J Mol Sci 24(4)","DOI":"10.3390\/ijms24043219"},{"key":"11986_CR101","doi-asserted-by":"publisher","first-page":"110075","DOI":"10.1016\/j.intimp.2023.110075","volume":"118","author":"W Luo","year":"2023","unstructured":"Luo W, Zhang G, Wang Z, Wu Y, Xiong Y (2023) Ubiquitin-specific proteases: Vital regulatory molecules in bone and bone-related diseases. Int Immunopharmacol 118:110075","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"11986_CR102","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.3892\/ijo.2015.2901","volume":"46","author":"SR Kim","year":"2015","unstructured":"Kim SR, Kim JO, Lim KH, Yun JH, Han I, Baek KH (2015) Regulation of pyruvate kinase isozyme M2 is mediated by the ubiquitin-specific protease 20. Int J Oncol 46(5):2116\u20132124","journal-title":"Int J Oncol"},{"issue":"6","key":"11986_CR103","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1007\/s13402-024-01002-z","volume":"47","author":"Q Qiao","year":"2024","unstructured":"Qiao Q, Wang J, Liu S, Chang J, Zhou T, Li C, Zhang Y, Jiang W, Chen Y, Xu X et al (2024) USP28 promotes tumor progression and glycolysis by stabilizing PKM2\/Hif1-\u03b1 in cholangiocarcinoma. Cell Oncol (Dordr) 47(6):2217\u20132231","journal-title":"Cell Oncol (Dordr)"},{"key":"11986_CR104","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.freeradbiomed.2020.10.307","volume":"162","author":"LJ Tang","year":"2021","unstructured":"Tang LJ, Zhou YJ, Xiong XM, Li NS, Zhang JJ, Luo XJ, Peng J (2021) Ubiquitin-specific protease 7 promotes ferroptosis via activation of the p53\/TfR1 pathway in the rat hearts after ischemia\/reperfusion. Free Radic Biol Med 162:339\u2013352","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"11986_CR105","doi-asserted-by":"publisher","first-page":"189099","DOI":"10.1016\/j.bbcan.2024.189099","volume":"1879","author":"H Gao","year":"2024","unstructured":"Gao H, Chen Z, Zhao L, Ji C, Xing F (2024) Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment. Biochim Biophys Acta Rev Cancer 1879(3):189099","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"11986_CR106","doi-asserted-by":"publisher","first-page":"103734","DOI":"10.1016\/j.jprot.2020.103734","volume":"219","author":"VC Silvestrini","year":"2020","unstructured":"Silvestrini VC, Thom\u00e9 CH, Albuquerque D, de Souza Palma C, Ferreira GA, Lanfredi GP, Masson AP, Delsin LEA, Ferreira FU, de Souza FC et al (2020) Proteomics analysis reveals the role of ubiquitin specific protease (USP47) in Epithelial to Mesenchymal Transition (EMT) induced by TGF\u03b22 in breast cells. J Proteom 219:103734","journal-title":"J Proteom"},{"issue":"1","key":"11986_CR107","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41419-025-07886-5","volume":"16","author":"T Zhao","year":"2025","unstructured":"Zhao T, Chen X, Wu J, Chen S, Gan Y, Liu C, Ha X, Wu Y, Zhou X, Wu Y et al (2025) YY1-induced USP43 drives ferroptosis suppression by FASN stabilization and subsequent activation of SLC7A11 in ovarian cancer. Cell Death Dis 16(1):589","journal-title":"Cell Death Dis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11986-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11986-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11986-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:01:58Z","timestamp":1779447718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11986-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11986"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11986-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"There is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"808"}}